XSHG600223
Market cap988mUSD
Jan 09, Last price
7.08CNY
1D
0.42%
1Q
-0.83%
Jan 2017
31.07%
Name
Lushang Property Co Ltd
Chart & Performance
Profile
Lushang Health Industry Development Co.,Ltd. develops and operates real estate properties in China. It develops residences, commercial complexes, shopping malls, high-end office buildings, star hotels, and other projects. The company was formerly known as Lushang Property Co., Ltd. and changed its name to Lushang Health Industry Development Co.,Ltd. in June 2019. Lushang Health Industry Development Co.,Ltd. is based in Jinan, China. Lushang Health Industry Development Co.,Ltd. is a subsidiary of Shandong Province Commercial Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 4,578,746 -64.65% | 12,951,443 4.76% | |||||||
Cost of revenue | 3,985,647 | 11,299,874 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 593,099 | 1,651,569 | |||||||
NOPBT Margin | 12.95% | 12.75% | |||||||
Operating Taxes | 46,823 | 195,960 | |||||||
Tax Rate | 7.89% | 11.87% | |||||||
NOPAT | 546,276 | 1,455,609 | |||||||
Net income | 303,387 366.04% | 65,098 -82.01% | |||||||
Dividends | (487,955) | (111,007) | |||||||
Dividend yield | 5.01% | 0.92% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 705,224 | 5,498,040 | |||||||
Long-term debt | 690,117 | 2,257,969 | |||||||
Deferred revenue | 55,179 | 55,626 | |||||||
Other long-term liabilities | 890 | 1 | |||||||
Net debt | (576,304) | 2,504,013 | |||||||
Cash flow | |||||||||
Cash from operating activities | 536,841 | 998,095 | |||||||
CAPEX | (211,368) | (166,115) | |||||||
Cash from investing activities | 2,608,813 | 1,236 | |||||||
Cash from financing activities | (3,095,721) | ||||||||
FCF | 4,300,645 | 3,183,097 | |||||||
Balance | |||||||||
Cash | 1,733,585 | 4,317,970 | |||||||
Long term investments | 238,060 | 934,026 | |||||||
Excess cash | 1,742,708 | 4,604,424 | |||||||
Stockholders' equity | 3,818,929 | 4,937,123 | |||||||
Invested Capital | 4,375,859 | 7,906,329 | |||||||
ROIC | 8.90% | 16.16% | |||||||
ROCE | 9.69% | 13.19% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,011,291 | 1,136,384 | |||||||
Price | 9.63 -9.07% | 10.59 -20.08% | |||||||
Market cap | 9,738,728 -19.08% | 12,034,302 -12.16% | |||||||
EV | 9,827,798 | 16,388,500 | |||||||
EBITDA | 740,858 | 1,773,168 | |||||||
EV/EBITDA | 13.27 | 9.24 | |||||||
Interest | 103,312 | 400,970 | |||||||
Interest/NOPBT | 17.42% | 24.28% |